Better Therapeutics (BTTX) Short Interest Ratio & Short Volume → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free BTTX Stock Alerts $0.01 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Better Therapeutics Short Interest DataCurrent Short Volume2,560,000 sharesPrevious Short Volume2,130,000 sharesChange Vs. Previous Month+20.19%Dollar Volume Sold Short$114,176.00Short Interest Ratio / Days to Cover0.4Last Record DateMarch 15, 2024Outstanding Shares49,860,000 sharesFloat Size30,890,000 sharesShort Percent of Float8.29%Today's Trading Volume133,960 sharesAverage Trading Volume4,471,536 sharesToday's Volume Vs. Average3% Short Selling Better Therapeutics ? Sign up to receive the latest short interest report for Better Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBTTX Short Interest Over TimeBTTX Days to Cover Over TimeBTTX Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Better Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20242,560,000 shares $114,176.00 +20.2%8.3%0.4 $0.04 2/29/20242,130,000 shares $338,031.00 +7.0%7.4%0.9 $0.16 2/15/20241,990,000 shares $405,960.00 +107.1%6.9%1 $0.20 1/31/2024960,700 shares $181,764.44 -29.9%3.4%0.5 $0.19 1/15/20241,370,000 shares $319,621.00 +20.2%5.7%0.8 $0.23 12/31/20231,140,000 shares $222,300.00 -38.0%4.5%0.4 $0.20 Get the Latest News and Ratings for BTTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Better Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20231,840,000 shares $461,840.00 -39.1%7.6%0.9 $0.25 11/30/20233,020,000 shares $591,618.00 -2.3%13.0%1.5 $0.20 11/15/20233,090,000 shares $501,507.00 +94.3%13.3%1.7 $0.16 10/31/20231,590,000 shares $227,052.00 +117.5%8.3%1 $0.14 10/15/2023731,200 shares $229,450.56 +201.8%4.4%0.5 $0.31 9/30/2023242,300 shares $88,681.80 +6.7%1.2%0.3 $0.37 9/15/2023227,100 shares $113,663.55 -14.9%1.1%0.3 $0.50 8/31/2023267,000 shares $165,566.70 -6.7%1.3%0.3 $0.62 8/15/2023286,200 shares $189,206.82 +79.0%1.4%0.3 $0.66 7/31/2023159,900 shares $119,365.35 -68.1%1.0%0.2 $0.75 7/15/2023500,500 shares $425,525.10 +752.6%4.9%0.6 $0.85 6/30/202358,700 shares $63,396.00 +7.1%0.6%0.1 $1.08 6/15/202354,800 shares $53,698.52 -38.3%0.5%0.3 $0.98 5/31/202388,800 shares $62,168.88 -42.6%2.8%0.6 $0.70 5/15/2023154,600 shares $121,067.26 +19.1%4.8%1.2 $0.78 4/30/2023129,800 shares $151,217.00 -30.3%6.7%1.2 $1.17 4/15/2023186,200 shares $245,784.00 +51.4%8.1%2.4 $1.32 3/31/2023123,000 shares $86,100.00 +21.3%1.5%2.1 $0.70 3/15/2023101,400 shares $94,302.00 +18.0%1.2%3.4 $0.93 2/28/202385,900 shares $103,080.00 -21.5%1.1%3 $1.20 2/15/2023109,400 shares $132,384.94 +2.7%1.4%3.9 $1.21 1/31/2023106,500 shares $145,905.00 -30.7%1.4%3.3 $1.37 1/15/2023153,600 shares $211,968.00 +6.6%2.0%4.1 $1.38 12/30/2022144,100 shares $159,230.50 +17.4%1.9%3.6 $1.11 12/15/2022122,800 shares $171,920.00 +20.6%1.6%2.9 $1.40 11/30/2022101,800 shares $148,628.00 +39.8%1.3%1.5 $1.46 11/15/202272,800 shares $104,832.00 -38.2%1.0%0.9 $1.44 10/31/2022117,700 shares $182,435.00 +22.6%1.5%0.9 $1.55 10/15/202296,000 shares $149,760.00 +15.3%1.3%0.1 $1.56 9/30/202283,300 shares $146,608.00 -15.1%1.1%0.1 $1.76 9/15/202298,100 shares $201,105.00 -58.4%1.3%0.1 $2.05 8/31/2022235,600 shares $402,876.00 +161.5%3.0%0.2 $1.71 8/15/202290,100 shares $163,081.00 +55.3%1.2%0 $1.81 7/31/202258,000 shares $128,760.00 -74.3%0.8%0 $2.22A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. BTTX Short Interest - Frequently Asked Questions What is Better Therapeutics' current short interest? Short interest is the volume of Better Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 2,560,000 shares of BTTX short. 8.29% of Better Therapeutics' shares are currently sold short. Learn More on Better Therapeutics' current short interest. What is a good short interest percentage for Better Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.29% of Better Therapeutics' floating shares are currently sold short. Is Better Therapeutics' short interest increasing or decreasing? Better Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,560,000 shares, an increase of 20.2% from the previous total of 2,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Better Therapeutics' float size? Better Therapeutics currently has issued a total of 49,860,000 shares. Some of Better Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Better Therapeutics currently has a public float of 30,890,000 shares. How does Better Therapeutics' short interest compare to its competitors? 8.29% of Better Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Better Therapeutics: Tivic Health Systems, Inc. (3.74%), Akanda Corp. (3.46%), Acorda Therapeutics, Inc. (0.66%), Scinai Immunotherapeutics Ltd. (0.47%), SciSparc Ltd. (4.18%), Sunshine Biopharma, Inc. (29.84%), Evelo Biosciences, Inc. (2.11%), Aditxt, Inc. (8.48%), China SXT Pharmaceuticals, Inc. (2.63%), Bone Biologics Co. (3.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Better Therapeutics stock? Short selling BTTX is an investing strategy that aims to generate trading profit from Better Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Better Therapeutics? A short squeeze for Better Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BTTX, which in turn drives the price of the stock up even further. How often is Better Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTTX, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Tivic Health Systems Short Interest Akanda Short Interest Acorda Therapeutics Short Interest Scinai Immunotherapeutics Short Interest SciSparc Short Interest Sunshine Biopharma Short Interest Evelo Biosciences Short Interest Aditxt Short Interest China SXT Pharmaceuticals Short Interest Bone Biologics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BTTX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA ‘DeFi Summer’ Projected!Crypto 101 MediaUrgent Nvidia WarningAltimetryBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin Analytics